Your browser doesn't support javascript.
loading
Phase I/II trial of vorinostat, bevacizumab, and daily temozolomide for recurrent malignant gliomas.
Peters, Katherine B; Lipp, Eric S; Miller, Elizabeth; Herndon, James E; McSherry, Frances; Desjardins, Annick; Reardon, David A; Friedman, Henry S.
Afiliação
  • Peters KB; Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine, DUMC 3624, Durham, NC, 27710, USA. katherine.peters@duke.edu.
  • Lipp ES; Department of Neurosurgery, Duke University Medical Center, Durham, NC, USA. katherine.peters@duke.edu.
  • Miller E; Department of Neurology, Duke University Medical Center, Durham, NC, USA. katherine.peters@duke.edu.
  • Herndon JE; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA. katherine.peters@duke.edu.
  • McSherry F; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
  • Desjardins A; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
  • Reardon DA; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC, USA.
  • Friedman HS; Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA.
J Neurooncol ; 137(2): 349-356, 2018 Apr.
Article em En | MEDLINE | ID: mdl-29264836
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Bevacizumab / Temozolomida / Vorinostat / Glioma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Bevacizumab / Temozolomida / Vorinostat / Glioma / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: J Neurooncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos